Esperion Therapeutics, Inc. (LON:0IIM)
London · Delayed Price · Currency is GBP · Price in USD 1.367
-0.041 (-2.91%)
At close: Aug 1, 2025
Zuora Market Cap
Esperion Therapeutics has a market cap or net worth of 209.48 million as of August 1, 2025. Its market cap has decreased by -45.11% in one year.
Market Cap
209.48M
Enterprise Value
571.38M
Revenue
200.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.37
Market Cap Chart
Since June 26, 2013, Esperion Therapeutics's market cap has increased from 137.93M to 209.48M, an increase of 51.88%. That is a compound annual growth rate of 3.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 209.48M | -39.50% |
| Dec 31, 2024 | 346.25M | 29.71% |
| Dec 29, 2023 | 266.94M | -29.93% |
| Dec 30, 2022 | 380.99M | 68.53% |
| Dec 31, 2021 | 226.06M | -57.42% |
| Dec 31, 2020 | 530.87M | -56.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 178.30B |
| GSK plc | 59.04B |
| Haleon | 32.79B |
| Smith & Nephew | 10.24B |
| ConvaTec Group | 4.72B |
| Hikma Pharmaceuticals | 4.40B |
| HUTCHMED (China) | 2.34B |
| Oxford Nanopore Technologies | 1.94B |